The prevalence of various forms of peripheral neuropathy has not been previously assessed in 
Cryoglobulinaemia is a condition characterised by the presence of serum proteins reversibly precipitating in the cold, composed of isolated monoclonal immunoglobulin (cryoglobulin type I) or with a monoclonal component (type II) or composed only of polyclonal immunoglobulins (type III).' Cryoglobulinaemia may be idiopathic (essential mixed cryoglobulinaemia (EMG)) or secondary to other diseases, such as lymphoproliferative disorders, collagen diseases, and chronic infections.' Peripheral neuropathy associated with cryoglobulinaemia has long been described,2 most reports, however, deal with single cases3-4 or small groups of patients.'"20 The data on the prevalence of peripheral neuropathy in cryoglobulinaemia are inconsistent, ranging from quite low estimates (7%-19%)' 15 16 Muscle examination with concentric needle electrode and nerve conduction studies were performed in 23 patients with clinically suspected neuropathy. Motor and sensory nerve conduction studies were performed with surface electrodes for stimulation and recording. Motor nerve conduction velocities (MNCV) and motor action potentials (MAP) were evaluated bilaterally in the peroneal nerve of all patients. Sensory conduction studies were performed antidromically in the sural nerves. Sensory action potentials (SAP) of the sural nerves were obtained by averaging 32-256 responses. MNCV of the median, ulnar, and tibial nerves and sensory nerve conduction velocities (SNCV) of the median, ulnar, and superficial peroneal nerves were also examined in selected patients. Electromyography (EMG) was performed with concentric needle electrodes in the distal muscles of the legs. When the neuropathy was focal or multifocal, the corresponding muscles and nerves were additionally examined. Limb temperature was maintained at 360 C with an infrared heating lamp throughout the examination. Biopsy specimens of the sural nerve 5 cm above the external malleolus and of the peroneus brevis muscle were obtained under local anesthesia in nine patients. Muscle and nerve biopsy specimens were processed with standard methods for histology, histochemistry, and electron microscopy, and for single fibre preparation (eight patients).26 Morphometric study of the distribution of myelinated fibre population was performed on photomicrographs of semithin sections at a magnification of x 1000, covering at least 0-1 mm2 of endoneurial area, with an image analyser (MiniMOP, Zeiss Italia). Necrotising vasculitis was diagnosed according to the criteria of Wees et al27 and Dyck et al,28 when intramural infiltration with necrosis of the vessel walls was present. Otherwise, pathological changes were considered suggestive but not diagnostic of vasculitis, or representative of healed vasculitis in the presence of infiltration or necrosis of the vessel wall, or perivascular inflammation, or fibrous scarring and intramural thickening of the vessel walls,2728 Direct immunofluorescence on frozen nerve sections was performed with anti-sera coupled to fluorescein isothiocyanate.
Results
Clinicalfindings A total of 37 EMC patients (33 women, four men) were examined during the study. Peripheral neuropathy was clinically suspected in 23 patients, but the diagnosis was confirmed in only 21 patients (17 women, four men) by electrophysiological investigation. Other possible causes of peripheral neuropathy were excluded. The 16 remaining women who did not show evidence of peripheral neuropathy, including two patients in whom electrophysiological examination was completely normal in spite of clinical suspicion of neuropathy, represented the "control" group of nonneuropathic EMC patients. Thus, peripheral neuropathy probably related to EMC was found in 21 out of 37 patients (56-8%), with a prevalence similar or slightly lower than other common manifestations of EMC in our series, such as purpura (70 3%), arthritis (67-6%), and fever (48-6%). The time elapsed between onset of EMC and clinical observation was similar in patients with peripheral neuropathy (range 4 months-30 years; median 2 years) and in "controls" (range 3 months-27 years; median 2-5 years). Table 1 summarises the clinical features of peripheral neuropathy. Polyneuropathy was present in 19 patients, seventeen had a pure or mainly sensory type characterised by painful dysesthesias and sensory loss in a stocking distribution. Although polyneuropathy was often asymmetrical, extensive mononeuritis multiplex was excluded as temporal and spatial rather than inflammatory reaction, and this could account for endoneurial vessel changes, similar to the putative mechanism involved in the damage of glomerular capillaries."
